Comorbidity as a driver of adverse outcomes in people with chronic kidney disease

Marcello Tonelli, Natasha Wiebe, Bruce Guthrie, Matthew T James, Hude Quan, Martin Fortin, Scott W Klarenbach, Peter Sargious, Sharon Straus, Richard Lewanczuk, Paul E Ronksley, Braden J Manns, Brenda R Hemmelgarn, Marcello Tonelli, Natasha Wiebe, Bruce Guthrie, Matthew T James, Hude Quan, Martin Fortin, Scott W Klarenbach, Peter Sargious, Sharon Straus, Richard Lewanczuk, Paul E Ronksley, Braden J Manns, Brenda R Hemmelgarn

Abstract

Chronic kidney disease (CKD) is associated with poor outcomes, perhaps due to a high burden of comorbidity. Most studies of CKD populations focus on concordant comorbidities, which cause CKD (such as hypertension and diabetes) or often accompany CKD (such as heart failure or coronary disease). Less is known about the burden of mental health conditions and discordant conditions (those not concordant but still clinically relevant, like dementia or cancer). Here we did a retrospective population-based cohort study of 530,771 adults with CKD residing in Alberta, Canada between 2003 and 2011. Validated algorithms were applied to data from the provincial health ministry to assess the presence/absence of 29 chronic comorbidities. Linkage between comorbidity burden and adverse clinical outcomes (mortality, hospitalization or myocardial infarction) was examined over median follow-up of 48 months. Comorbidities were classified into three categories: concordant, mental health/chronic pain, and discordant. The median number of comorbidities was 1 (range 0-15) but a substantial proportion of participants had 3 and more, or 5 and more comorbidities (25 and 7%, respectively). Concordant comorbidities were associated with excess risk of hospitalization, but so were discordant comorbidities and mental health conditions. Thus, discordant comorbidities and mental health conditions as well as concordant comorbidities are important independent drivers of the adverse outcomes associated with CKD.

References

    1. N Engl J Med. 1998 May 21;338(21):1516-20
    1. J Clin Epidemiol. 2012 Jan;65(1):100-6
    1. JAMA. 2010 Feb 3;303(5):423-9
    1. Lancet. 2012 Jul 7;380(9836):37-43
    1. Lancet. 2010 Aug 28;376(9742):667-9
    1. Am J Public Health. 1998 Jan;88(1):15-9
    1. J Clin Epidemiol. 2012 Oct;65(10):1041-51
    1. BMC Fam Pract. 2011 Jul 13;12:74
    1. Can Fam Physician. 2005 Feb;51:244-5
    1. BMC Fam Pract. 2014 Jun 11;15:117
    1. BMJ Open. 2013 Jul 19;3(7):null
    1. J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):301-11
    1. Lancet. 2007 Oct 20;370(9596):1453-7
    1. JAMA. 2005 Apr 13;293(14):1737-45
    1. Public Health Rep. 2011 Jul-Aug;126(4):460-71
    1. BMC Health Serv Res. 2010 May 06;10:111
    1. BMC Med Inform Decis Mak. 2015 Apr 17;15:31
    1. Diabetes Care. 2006 Mar;29(3):725-31
    1. Am Heart J. 2002 Aug;144(2):290-6
    1. JAMA. 2005 Aug 10;294(6):716-24
    1. BMC Nephrol. 2009 Oct 19;10:30
    1. Med Care Res Rev. 2011 Aug;68(4):387-420
    1. Ann Intern Med. 2013 Jun 4;158(11):825-30

Source: PubMed

3
Subscribe